13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

Page 9 of 9

Page 9 of 9 – SEC Filing

Schedule II
The business and operations of OrbiMed Capital GP III LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I.

Follow Pieris Pharmaceuticals Inc. (NYSE:PIRS)

Page 9 of 9